XML 43 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Class A Common Stock [Member]
Retained Earnings
Accumulated Other Comprehensive Loss
Total Stockholders' Equity - Dolby Laboratories, Inc.
Noncontrolling Interest
Beginning balance (in shares) at Sep. 24, 2021   100,000            
Beginning balance at Sep. 24, 2021 $ 2,604,232   $ 0   $ 2,607,909 $ (10,030) $ 2,597,979 $ 6,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 156,139       156,331   156,331 (192)
Other comprehensive loss, net of tax (20,608)         (20,396) (20,396) (212)
Distributions to noncontrolling interest (1,435)             (1,435)
Stock-based compensation expense 87,963   87,963       87,963  
Repurchase of common stock (in shares)   (4,000)            
Repurchase of common stock (310,486)   (107,567)   (202,915)   (310,486)  
Cash dividends declared and paid on common stock (75,816)       (75,816)   (75,816)  
Common stock issued under employee stock plans 53,600 $ 2 53,598       53,600  
Tax withholdings on vesting of restricted stock (33,994)     $ (33,994)     (33,994)  
Deconsolidation of subsidiary (70)       (820)   (820) 750
Ending balance (in shares) at Jul. 01, 2022   98,000            
Ending balance at Jul. 01, 2022 2,459,525   0   2,484,689 (30,426) 2,454,361 5,164
Beginning balance (in shares) at Apr. 01, 2022   99,000            
Beginning balance at Apr. 01, 2022 2,605,188   0   2,615,354 (15,681) 2,599,772 5,416
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 39,610       39,597   39,597 13
Other comprehensive loss, net of tax (15,010)         (14,745) (14,745) (265)
Stock-based compensation expense 27,608   27,608       27,608  
Repurchase of common stock (in shares)   (2,000)            
Repurchase of common stock (190,000)   (44,871)   (145,127)   (190,000)  
Cash dividends declared and paid on common stock (25,135)       (25,135)   (25,135)  
Common stock issued under employee stock plans 18,538 $ 1 18,537       18,538  
Tax withholdings on vesting of restricted stock (1,274)     (1,274)     (1,274)  
Ending balance (in shares) at Jul. 01, 2022   98,000            
Ending balance at Jul. 01, 2022 2,459,525   0   2,484,689 (30,426) 2,454,361 5,164
Beginning balance (in shares) at Sep. 30, 2022   94,000            
Beginning balance at Sep. 30, 2022 2,251,020   0   2,297,730 (51,641) 2,246,183 4,837
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 191,736       191,470   191,470 266
Other comprehensive loss, net of tax 20,932         20,478 20,478 454
Distributions to noncontrolling interest (266)             (266)
Stock-based compensation expense 90,291   90,291       90,291  
Capitalized stock-based compensation expense $ 1,060   1,060       1,060  
Repurchase of common stock (in shares) (1,606,700) (2,000)            
Repurchase of common stock $ (124,276)   (109,965)   (14,309)   (124,276)  
Cash dividends declared and paid on common stock (77,584)       (77,584)   (77,584)  
Common stock issued under employee stock plans 37,231 $ 2 37,229       37,231  
Tax withholdings on vesting of restricted stock (28,619)     (28,619)     (28,619)  
Equity issued in connection with business combination 21,198   10,004       10,004 11,194
Ending balance (in shares) at Jun. 30, 2023   94,000            
Ending balance at Jun. 30, 2023 2,382,723   0   2,397,307 (31,163) 2,366,238 16,485
Beginning balance (in shares) at Mar. 31, 2023   95,000            
Beginning balance at Mar. 31, 2023 2,355,992   0   2,378,115 (27,426) 2,350,784 5,208
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 16,405       16,399   16,399 6
Other comprehensive loss, net of tax (3,660)         (3,737) (3,737) 77
Stock-based compensation expense 29,224   29,224       29,224  
Capitalized stock-based compensation expense 389   389       389  
Repurchase of common stock (in shares)   (1,000)            
Repurchase of common stock (25,000)   (53,635)   28,636   (25,000)  
Cash dividends declared and paid on common stock (25,843)       (25,843)   (25,843)  
Common stock issued under employee stock plans 15,837   15,837       15,837  
Tax withholdings on vesting of restricted stock (1,819)     $ (1,819)     (1,819)  
Equity issued in connection with business combination 21,198   10,004       10,004 11,194
Ending balance (in shares) at Jun. 30, 2023   94,000            
Ending balance at Jun. 30, 2023 $ 2,382,723   $ 0   $ 2,397,307 $ (31,163) $ 2,366,238 $ 16,485